ACTRN12618001633279Completed未知
Evaluation of the Efficacy of Sugammadex Based on Ideal Body Weight of Obstetric Patients with Different Groups of Body Mass Indexes for Reversal of Moderate Rocuronium-Induced Neuromuscular Blockade
Basak ALTIPARMAK0 sites90 target enrollmentStarted: October 3, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 90
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Non-randomised trial
- Primary Purpose
- Diagnosis
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- Female
Inclusion Criteria
- •The patients over 18 years old with ASA status II and scheduled for an elective caesarean section under general anesthesia
Exclusion Criteria
- •presence of pulmonary diseases (asthma, chronic obstructive pulmonary disease etc), known allergy to study drugs, use of medications that can affect neuromuscular blockade such as magnesium sulphate, anticonvulsive drugs, macrolids and aminoglycosides, decline participation to the study
Investigators
Similar Trials
Not yet recruiting
Phase 4
Comparative study to find the effective dose of sugammadex to reverse the eefectbof muscle relaxants in patients undergoing General Surgery receiving muscle relaxants in general anesthesiaCTRI/2024/06/068590Vijayanagar Institute of Medical Sciences
Not yet recruiting
Unknown
To Evaluate the Efficacy of Sugammadex in Reversing the effect of a Muscle Relaxant in Patients Undergoing Major Upper Abdominal Surgery: An Observational StudyCTRI/2023/07/055172Dr. Ram Manohar Lohia Institute of Medical Sciences
Active, not recruiting
Not Applicable
Comparison of effects of sugammadex administration timing on the success rate of neuromuscular function monitoring before endotracheal tube extubation and recovery profile in patients undergoing general anesthesiaKCT0007899Konyang University Hospital80
Not yet recruiting
Unknown
Comparison of the effects of sugamadex dosage on the reversal of neuromuscular blockadeand recovery profile in adult patients under general anesthesiaKCT0008773Konyang University Hospital52
Active, not recruiting
Phase 1
Evaluation of the efficacy and safety of sugammadex (Bridion) in children with renal failure. - sugammadex in children with renal failureSugammadex is a selective relaxant binding agent, which is administered in case of a rocuronium-induced neuromuscular block, during general anaesthesia. The aim of the trial is to investigate the use, efficacy and safety of sugammadex in children (2-17 years) with moderate to severe renal failure (creatinine clearance < 30 ml/min), compared to children with normal renal function.MedDRA version: 9.1Level: HLTClassification code 10038443Term: Renal failure and impairmentMedDRA version: 9.1Level: LLTClassification code 10009119Term: Chronic renal failureMedDRA version: 9.1Level: LLTClassification code 10014647Term: End stage renal failureEUCTR2008-008246-20-NLRadboud University Nijmegen Medical Center, Department of Anaesthesiology, Pain and Palliative Medic20